Related references
Note: Only part of the references are listed.Controversy and Debate: Questionable utility of the relative risk in clinical research: Paper 1: A call for change to practice
Suhail A. Doi et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2022)
Dose-effect meta-analysis for psychopharmacological interventions using randomised data
Tasnim Hamza et al.
EVIDENCE-BASED MENTAL HEALTH (2022)
Blood Pressure Effects of Sodium Reduction Dose-Response Meta-Analysis of Experimental Studies
Tommaso Filippini et al.
CIRCULATION (2021)
Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review
Anthony D. Bai et al.
BMC MEDICAL RESEARCH METHODOLOGY (2021)
Empiric antibiotics for community-acquired pneumonia in adult patients: a systematic review and a network meta-analysis
Lara Montes-Andujar et al.
THORAX (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Examination of Dosing of Antipsychotic Drugs for Relapse Prevention in Patients With Stable Schizophrenia A Meta-analysis
Stefan Leucht et al.
JAMA PSYCHIATRY (2021)
Potassium Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials
Tommaso Filippini et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
One-stage dose-response meta-analysis for aggregated data
Alessio Crippa et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2019)
Oral versus Intravenous Antibiotics for Bone and Joint Infection
H. -K. Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Pitfalls of using the risk ratio in meta-analysis
Ilyas Bakbergenuly et al.
RESEARCH SYNTHESIS METHODS (2019)
Incorporating Patient Preferences in Noninferiority Trials
Sergio A. Acuna et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Diagnosis and Treatment of Adults with Community-acquired Pneumonia An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
Joshua P. Metlay et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Short- vs long-course antibiotic therapy for pneumonia: a comparison of systematic reviews and guidelines for the SIMI Choosing Wisely Campaign
Ludovico Furlan et al.
INTERNAL AND EMERGENCY MEDICINE (2019)
How to perform a meta-analysis with R: a practical tutorial
Sara Balduzzi et al.
EVIDENCE-BASED MENTAL HEALTH (2019)
Empirical Consequences of Current Recommendations for the Design and Interpretation of Noninferiority Trials
Scott K. Aberegg et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2018)
Systematic Review and Meta-analysis of the Efficacy of Short-Course Antibiotic Treatments for Community-Acquired Pneumonia in Adults
Giannoula S. Tansarli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Duration of Antibiotic Use Among Adults With Uncomplicated Community-Acquired Pneumonia Requiring Hospitalization in the United States
Sarah H. Yi et al.
CLINICAL INFECTIOUS DISEASES (2018)
Individualizing duration of antibiotic therapy in community-acquired pneumonia
Stefano Aliberti et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2017)
Multivariate Dose-Response Meta-Analysis: The dosresmeta R Package
Alessio Crippa et al.
JOURNAL OF STATISTICAL SOFTWARE (2016)
Duration of Antibiotic Treatment in Community-Acquired Pneumonia A Multicenter Randomized Clinical Trial
Ane Uranga et al.
JAMA INTERNAL MEDICINE (2016)
Comparative Effectiveness of Intravenous vs Oral Antibiotics for Postdischarge Treatment of Acute Osteomyelitis in Children
Ron Keren et al.
JAMA PEDIATRICS (2015)
Antibiotics for community-acquired pneumonia in adult outpatients
Smita Pakhale et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
How to Use a Noninferiority Trial Users' Guides to the Medical Literature
Sohail M. Mulla et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Guidelines for the management of adult lower respiratory tract infections - Full version
M. Woodhead et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia
S. Aliberti et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Position Paper: Recommended Design Features of Future Clinical Trials of Antibacterial Agents for Community-Acquired Pneumonia
Brad Spellberg et al.
CLINICAL INFECTIOUS DISEASES (2008)
Short- versus long-course antibacterial therapy for community-acquired pneumonia - A meta-analysis
George Dimopoulos et al.
DRUGS (2008)
Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study
Thomas M. File et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study
Rachida el Moussaoui et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia
G Tellier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Efficacy of a ten day course of ceftriaxone compared to a shortened five day course in the treatment of community-acquired pneumonia in hospitalized adults with risk factors.
P Léophonte et al.
MEDECINE ET MALADIES INFECTIEUSES (2002)
Share Paper
